Return-Path: Delivered-To: charley@transocean.com Received: from vps.transocean.com by vps.transocean.com with LMTP id KEGfOKmtw1rBFwAAInt2oQ for ; Tue, 03 Apr 2018 09:36:57 -0700 Return-path: Envelope-to: charley@transocean.com Delivery-date: Tue, 03 Apr 2018 09:36:57 -0700 Received: from omp.seminar.globalcompliancepanel.com ([129.145.68.201]:53612) by vps.transocean.com with esmtp (Exim 4.89_1) (envelope-from ) id 1f3OvU-0001eX-AG for charley@transocean.com; Tue, 03 Apr 2018 09:36:57 -0700 DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=globalcompliancepanel; d=seminar.globalcompliancepanel.com; h=MIME-Version:Content-Type:Content-Transfer-Encoding:Date:To:From:Reply-To: Subject:List-Unsubscribe:Message-ID; i=info@seminar.globalcompliancepanel.com; bh=o99OHMum18FLaC3GSU53P+Kejm+nHYwjc0GV1tHqFrY=; b=qsU8QSt0m4XhZvk7VghYs4r/Tglu/ZlHZQlCQiL5SAqXq5YIbe9KtIinkmcUQ/W5oh0pfTMN0lut 5ZkLqhYFv8lNBNSA5iLhaVF6B5LluhzcCCB9MWEPzahpi9QQbQAlEYNe1gvMADkF8NkvRvmCdNS2 w6A3AIL/CsrcsBjFVeU= Received: by omp.seminar.globalcompliancepanel.com id hoemq82b610d for ; Tue, 3 Apr 2018 09:36:12 -0700 (envelope-from ) X-CSA-Complaints: whitelist-complaints@eco.de MIME-Version: 1.0 Content-Type: text/html; charset="ISO-8859-1" Content-Transfer-Encoding: quoted-printable Date: Tue, 3 Apr 2018 09:36:12 -0700 To: charley@transocean.com From: =?ISO-8859-1?B?RE1GIGFuZCBRdWFsaXR5IEFncmVlbWVudCBUcmFpbmluZw==?= Reply-To: =?ISO-8859-1?B?RE1GIGFuZCBRdWFsaXR5IEFncmVlbWVudCBUcmFpbmluZw==?= Subject: The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities Feedback-ID: 10655:101402:oraclersys List-Unsubscribe: , X-sgxh1: JoHjtLPxljHgkhJLHgQJhu X-rext: 5.interact2.EsX-WUy29Ik4BrAGkJhIHSQsh94vKqjF_c6-4-lAF8TqZS4v1SQso3YjnOo X-cid: netzealou.44662 Message-ID: <0.0.104.449.1D3CB69E05CE5F0.0@omp.seminar.globalcompliancepanel.com> X-Spam-Status: No, score=2.4 X-Spam-Score: 24 X-Spam-Bar: ++ X-Ham-Report: Spam detection software, running on the system "vps.transocean.com", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities Your Gateway to Regulatory Compliance View Online About Us Webinars($10) Seminars Past Seminar Pictures Use MGCP50 Promo Code to GET FLAT 50% OFF on ALL SEMINARS - Offer Ends Today 2-day In-person Seminar The Use of Drug Master Files & Quality Agreements: Understanding and Meeting your Regulatory and Processing Responsibilities Click Here for More Details! Overview: This combined DMF (Drug Master Files) and Quality Agreement training will discuss the advantages for suppliers and drug product manufacturers in developing these arrangements together. [...] Content analysis details: (2.4 points, 3.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: globalcompliancepanel.com] -0.0 T_RP_MATCHES_RCVD Envelope sender domain matches handover relay domain -0.0 SPF_PASS SPF: sender matches SPF record 0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60% [score: 0.4892] 0.0 HTML_MESSAGE BODY: HTML included in message 0.7 MIME_HTML_ONLY BODY: Message only has text/html MIME parts -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain 1.0 FROM_EXCESS_BASE64 From: base64 encoded unnecessarily X-Spam-Flag: NO <=21DOCTYPE html PUBLIC =22-//W3C//DTD XHTML 1=2E0 Transitional//EN=22 =22h= ttp://www=2Ew3=2Eorg/TR/xhtml1/DTD/xhtml1-transitional=2Edtd=22> The Use of Drug Master Files & Quality Agreements: Understanding = and Meeting your Regulatory and Processing Responsibilities <=21-- START OF PRE-HEADER A= REA BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= EFT COLUMN--> <=21-- START OF TEXT--> <=21-- END OF TEXT-->
Your Gateway to Regulatory Compliance View Online
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--><=21-- END OF RIGHT COLUMN-->
<=21-- END OF PRE-HEADER AREA BLOCK--><=21-- START OF HEADER BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= OGO-->
3D=22logo=22
<=21-- END OF LOGO--><=21-- START OF SP= ACER-->
About Us= Webinars(=2410) Seminars
Past Seminar Picture= s
=
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF HEADER BLOCK--><=21-- START OF FEATURED AREA BLOCK-->
3D=22top
Use MGCP50 Promo Code to GET FLAT 50% O= FF on ALL SEMINARS - Offer Ends Today
<=21-- START OF VERTICAL SPACER-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF LEFT COLUM= N--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- START BUTTO= N--> <=21-- END BUTTON-->
2-day In-person Seminar
The Use of Drug Master Files & Quality Agreements:= Understanding and Meeting your Regulatory and Processing Responsibilities<= /span>
Click Here fo= r More Details=21
<=21-- END OF LEFT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
3D=22bottom
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF FEATURED AREA BLOCK--><=21-- START OF 1/1 (FULL WIDTH) INTRO = TEXT BLOCK-->
<=21-- START OF TEXT--> <=21-- END OF TEXT-->
Overview: This combined DMF (Dru= g Master Files) and Quality Agreement training will discuss the advantages = for suppliers and drug product manufacturers in developing these arrangemen= ts together=2E

Over time, there have been sev= eral misunderstandings between supplier / contractors and pharmaceutical / = biologic finished product manufacturers=2E The root of many of the problems= lie in a lack of a suitable agreement delineating roles, responsibilities = and resolution to agreement to these issues=2E Part of these arrangements t= ypically involve the development, support and updating of confidential tech= nical files (Drug Master files), which allow suppliers to protect their con= fidential product and process information from each and every customer and = share it only with the Agency=2E Read more=2E=2E=2E
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF 1/1 (FULL WIDTH) INTRO TEXT BLOCK--><=21-- START OF DIVIDER I= MAGE BLOCK-->
3D=22divider
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF DIVIDER IMAGE BLOCK--><=21-- START OF 2/3 AND 1/3 COL RIGHT I= MAGE BLOCK-->
<=21-- START OF LEFT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT--><=21-- START= BUTTON-->
= Date & Time
Date: May 31st & June 1st, 2018
Time: 9:00 AM= to 6:00 PM
<=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT--><=21-- START= BUTTON-->
= Venue
Philadelphia, PA
DoubleTree by Hilton Philadelp= hia Airport
3D=22divider
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF DIVIDER IMAGE BLOCK--><=21-- START OF 1/3 AND 2/3 COL LEFT IM= AGE BLOCK-->
<=21-- START OF L= EFT COLUMN-->
3D=22img-160-160=22
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING--><=21-- ST= ART OF TEXT--> <=21-- END OF TEXT-->
= Robert Russell
President / CEO , RJR Consulting, Inc=2E <= /span>
Robert J=2E = Russell (Bob), is President / CEO of RJR Consulting, Inc=2E which = specializes in helping clients navigate through Global Regulatory Complianc= e requirements for Pharmaceuticals, Medical Devices, Biologics, Combination= Products and Dietary Supplement / OTC products=2E
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF 1/3 AND 2/3 COL LEFT IMAGE BLOCK--><=21-- START OF CALL TO AC= TION BLOCK-->
3D=22top
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- START OF L= EFT COLUMN--> <=21-- START OF HEADING--> <=21-- END OF HEADING-->
Reserve your Seat Now
<=21-- END OF LEFT COLUMN--><=21-- STAR= T OF SPACER-->
<=21-- END OF SPACER--><=21-- START OF = RIGHT COLUMN--> <=21-- START BUTTON--> <=21-- END BUTTON-->
Enrol= l Now=21
<=21-- END OF RIGHT COLUMN-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
3D=22bottom
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF CALL TO ACTION BLOCK--><=21-- START OF SUB-FOOTER BLOCK-->
<=21-- START OF L= EFT COLUMN-->
GlobalComp= liancePanel
161 Mission Falls Lane, Suite = 216, Fremont, CA 94539, USA=2E
Phone: +1-800-447-9= 407
Fax: 302 288 6884<= /td>
ww= w=2Eglobalcompliancepanel=2Ecom =7C Unsubscribe<= /td>
Copyright © 2017 GlobalCo= mpliancePanel=2E All rights reserved=2E
<=21-- END OF LEFT COLUMN-->
<=21-- END OF SUB-FOOTER BLOCK--><=21-- START OF BOTTOM TEASER BLOCK-->
3D=22img
<=21-- END OF BOTTOM TEASER BLOCK--><=21-- START OF FOOTER BLOCK-->
<=21-- START OF VERTICAL SPACER-->
<=21-- END OF VERTICAL SPACER-->
<=21-- END OF FOOTER BLOCK-->